Nu-Med Plus (NUMD) Amortization - Intangibles (2016 - 2017)
Nu-Med Plus recorded quarterly Amortization - Intangibles of $21508.0 in Q1 2017, down 70.31% quarter-over-quarter from $72450.0 in Q4 2016, and up 412.84% year-over-year from $4193.9 in Q1 2016.
Nu-Med Plus' Amortization - Intangibles history runs 2 years deep, the most recent figure standing at $21508.0 for Q1 2017.
- In Q1 2017, Amortization - Intangibles rose 412.84% year-over-year to $21508.0; the TTM figure through Dec 2017 stood at $21508.0 (down 58.5% YoY), while the FY2017 annual figure was -$21508.0, down 141.5% from the prior year.
- Amortization - Intangibles came in at $21508.0 for Q1 2017 at Nu-Med Plus, down from $72450.0 in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $72450.0 in Q4 2016 to a low of -$6875.0 in Q1 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nu-Med Plus | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 21,508.00 |
| Dec 31, 2016 | 72,450.00 |
| Sep 30, 2016 | -6,875.00 |
| Jun 30, 2016 | -6,875.00 |
| Mar 31, 2016 | -6,875.00 |